Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma

Por Busino, Luca, Millman, Scott E., Scotto, Luigi, Kyratsous, Christos A., Basrur, Venkatesha, O’Connor, Owen, Hoffmann, Alexander, Elenitoba-Johnson, Kojo S., Pagano, Michele
Publicado em 2012

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including <it>Drosha</it>

Por Pothuri Bhavana, Wright Jason D, Kaufmann Andreas M, Subramaniyam Shivakumar, Nandula Subhadra V, Narayan Gopeshwar, Scotto Luigi, Mansukhani Mahesh, Schneider Achim, Arias-Pulido Hugo, Murty Vundavalli V
Publicado em 2008-06-01

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha

Por Scotto, Luigi, Narayan, Gopeshwar, Nandula, Subhadra V, Subramaniyam, Shivakumar, Kaufmann, Andreas M, Wright, Jason D, Pothuri, Bhavana, Mansukhani, Mahesh, Schneider, Achim, Arias-Pulido, Hugo, Murty, Vundavalli V
Publicado em 2008

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

Por Kalac, Matko, Scotto, Luigi, Marchi, Enrica, Amengual, Jennifer, Seshan, Venkatraman E., Bhagat, Govind, Ulahannan, Netha, Leshchenko, Violetta V., Temkin, Alexis M., Parekh, Samir, Tycko, Benjamin, O'Connor, Owen A.
Publicado em 2011

Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma

Por Zullo, Kelly M., Guo, Yige, Cooke, Laurence, Jirau-Serrano, Xavier, Mangone, Michael, Scotto, Luigi, Amengual, Jennifer E., Mao, Yinghui, Nandakumar, Renu, Cremers, Serge, Duong, Jimmy, Mahadevan, Daruka, O’Connor, Owen A.
Publicado no Clin Cancer Res (2015)

Dual targeting of protein degradation pathways with the selective HDAC6 inhibitor, ACY-1215, and bortezomib is synergistic in lymphoma

Por Amengual, Jennifer E., Johannet, Paul, Lombardo, Maximilian, Zullo, Kelly, Hoehn, Daniela, Bhagat, Govind, Scotto, Luigi, Jirau-Serrano, Xavier, Radeski, Dejan, Heinen, Jennifer, Jiang, Hongfeng, Cremers, Serge, Zhang, Yuan, Jones, Simon, O’Connor, Owen A.
Publicado no Clin Cancer Res (2015)

Protocadherin PCDH10, Involved in Tumor Progression, is a Frequent and Early Target of Promoter Hypermethylation in Cervical Cancer

Por Narayan, Gopeshwar, Scotto, Luigi, Neelakantan, Vijayalakshmi, Kottoor, Sherine H, Wong, Ada Ho Yan, Loke, Shee-Loong, Mansukhani, Mahesh, Pothuri, Bhavana, Wright, Jason D., Kaufmann, Andreas M., Schneider, Achim, Arias-Pulido, Hugo, Tao, Qian, Murty, Vundavalli V.
Publicado em 2009

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies

Por Deng, Changchun, Lipstein, Mark R., Scotto, Luigi, Jirau Serrano, Xavier O., Mangone, Michael A., Li, Shirong, Vendome, Jeremie, Hao, Yun, Xu, Xiaoming, Deng, Shi-Xian, Realubit, Ronald B., Tatonetti, Nicholas P., Karan, Charles, Lentzsch, Suzanne, Fruman, David A., Honig, Barry, Landry, Donald W., O’Connor, Owen A.
Publicado no Blood (2017)